GeneOhm Sciences

GeneOhm Sciences was a molecular diagnostics company specializing in the development of rapid nucleic acid-based tests for the detection of infectious diseases. Founded in 2001, the company focused on providing healthcare providers with fast, accurate results to improve patient management and infection control, particularly in hospital settings. Their flagship products included rapid assays for MRSA, Group B Streptococcus, and C. difficile, utilizing polymerase chain reaction (PCR) technology. In 2006, the company was acquired by BD (Becton, Dickinson and Company) for approximately $230 million. Today, its technologies are fully integrated into BD's diagnostic offerings, continuing to impact the field of clinical microbiology and infection prevention.